Immunome (NASDAQ:IMNM) Now Covered by Lifesci Capital
Investment analysts at Lifesci Capital assumed coverage on shares of Immunome (NASDAQ:IMNM – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $20.00 price target on the stock. Lifesci Capital’s price objective suggests a potential upside of 117.16% from the company’s current […]
Investment analysts at Lifesci Capital assumed coverage on shares of Immunome (NASDAQ:IMNM – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $20.00 price target on the stock. Lifesci Capital’s price objective suggests a potential upside of 117.16% from the company’s current […]
